Skip to main content

Table 1 Cell growth inhibition of HepG2 cells by 24 h treatment with 0.1–0.3% DMSO, RES or 5-FU

From: Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model

Cell growth inhibition ratio (%)
Cell groups   Res (μM) 5-FU (μM)
  DMSO 10 20 30 50 100 200 300 100
HepG2 0.046 11.88 17.49 22.03 30.50 45.95 51.45 65.93 50.86
CAV1 0.035 19.72 24.08* 37.13* 45.54* 57.54* 68.32* 87.89* 64.66*
CAVM1 15.97 22.63 25.03 33.82 45.98 55.78 72.34 48.48 0.047
CAVM2 13.91 19.39 26.44 34.77 47.55 57.27 76.56 42.46 0.029
RNAi 0.023 8.15 12.94 16.07* 24.34* 33.52* 41.23* 55.37* 32.83*
GFP 0.034 10.32 18.07 22.34 30.84 45.37 54.04 67.12 53.23
CAV1 0.035 19.72 24.08* 37.13* 45.54* 57.54* 68.32* 87.89* 64.66*
  1. *P < 0.05 vs control, [ ± SD, SD = 0.8~2.5), n = 3]
  2. RNAi = CAVRNAi